Insight Exchange – Can We Ever Reliably Predict Safety & Efficacy Before the Clinic?

• Which endpoints remain hardest to predict with current models?
• How should teams balance efficacy and safety when selecting models?
• What breakthroughs are needed to improve prediction of clinical outcomes?
• Audience Q&As

Speakers:

Sonja Gill

Director, Oncology Safety Combinations, Clinical Pharmacology & Safety Sciences

AstraZeneca

Andrew Whale

Director - Nonclinical Safety

Immunocore Ltd